Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage
2010
Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
1999
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares
2008
Oral Bile Acids Reduce Bacterial Overgrowth, Bacterial Translocation, and Endotoxemia in Cirrhotic Rats
2003
Controlled Trial on Nutrition Supplementation in Outpatients With Symptomatic Alcoholic Cirrhosis
1993
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
2015
Cytomegalovirus Colitis Complicating Inflammatory Bowel Disease
2006
Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression
2006
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Current concepts and controversies in the treatment of alcoholic hepatitis
2006
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
2019
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia
2002
Toll-like receptors as targets in chronic liver diseases
2009
Ulcerative Colitis
2011 Standout
Intestinal permeability and complications in liver cirrhosis: A prospective cohort study
2012
Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease
1995
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
2010
Human Genetics Shape the Gut Microbiome
2014 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis
2010
Dietary Beliefs and Behavior Among Inflammatory Bowel Disease Patients
2012
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates
2010
Nutrition for the liver transplant patient
2006
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
The Transjugular Intrahepatic Portosystemic Stent–Shunt Procedure for Refractory Ascites
1995
Nutritional status: its influence on the outcome of patients undergoing liver transplantation
2009
Spontaneous bacterial peritonitis: recent guidelines and beyond
2011
Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology
2014
Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials
2009
Small Intestine Dysmotility and Bacterial Overgrowth in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
1998
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients
2000
Branched-chain amino acids and ammonia metabolism in liver disease: Therapeutic implications
2013
Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage
2006
Use of thiopurines in inflammatory bowel disease: Safety issues
2014
Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism
2003
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
The MELD score in patients awaiting liver transplant: Strengths and weaknesses
2010
Adjuvant Nutrition Management of Patients with Liver Failure, Including Transplant
2011
Hepatocellular carcinoma
2012 Standout
Male Issues of the Ileal Pouch
2014
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
2016
Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients
2016
Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis
2006
American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease
2006
Ulcerative colitis
2002
Selenium and human health
2012 Standout
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
2005
Daily Norfloxacin Is More Effective Than Weekly Rufloxacin in Prevention of Spontaneous Bacterial Peritonitis Recurrence
2002
Epidemiology and risk factors for IBD
2015 Standout
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Anabolic-Androgenic Steroids for Alcoholic Liver Disease: A Cochrane Review
2002
Adhesion molecules as a prognostic marker of liver cirrhosis
2005
β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis
2009
Interactions Between the Dietary Polyunsaturated Fatty Acid Ratio and Genetic Factors Determine Susceptibility to Pediatric Crohn's Disease
2014
Evaluation of nutritional practice in hospitalized cirrhotic patients
2003
Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study
2008
Nutritional therapy in alcoholic liver disease
2003
Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis
1998
Celiac Disease
2007 Standout
Antioxidant enzymes and human diseases
1999 Standout
Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis
2001
Pathological bacterial translocation in liver cirrhosis
2013
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Short Bowel Syndrome and Intestinal Failure in Crohnʼs Disease
2016
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
1996
Alterations in intestinal microbial flora and human disease
2008
Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement
2003
Ulcerative colitis
2012 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Appendiceal Skip Inflammation and Ulcerative Colitis
2014
Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials
2006
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
MELD and PELD: Application of survival models to liver allocation
2001
Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato‐Biliary Group systematic review with meta‐analyses and trial sequential analyses of randomized clinical trials
2008
Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
2009
Cachexia in liver cirrhosis
2002
Intestinal barrier dysfunction in developing liver cirrhosis: An in vivo analysis of bacterial translocation
2007
Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis
2010
AGA technical review on parenteral nutrition
2001
Alcoholic liver disease
2001
Endoscopy in inflammatory bowel disease
2002
Investigation of Autonomic Function and Orocecal Transit Time in Patients With Nonalcoholic Cirrhosis and the Potential Influence of These Factors on Disease Outcome
2009
Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
2009
Intestinal permeability in cirrhotic patients with and without ascites
2005
Dilutional Hyponatremia in Patients With Cirrhosis and Ascites
2002
New Concepts in Intestinal Imaging for Inflammatory Bowel Diseases
2011
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Selenium and the prevention of prostate and colorectal cancer
2008
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial
2009
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Ulcerative colitis
2016 Standout
Nutrition in hepatic failure and liver transplantation
2001
Implication of inflammation‐related cytokines in the natural history of liver cirrhosis
2004
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
2008
Gut flora in health and disease
2003 Standout
Nutrition and survival in patients with liver cirrhosis
2001
Assessment of Intestinal Permeability and Absorption in Cirrhotic Patients with Ascites Using Combined Sugar Probes
2004
Prognostic impact of disease-related malnutrition
2007
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:
2009 Standout
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost
2005
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Effects of Oral Branched-Chain Amino Acid Granules on Event-Free Survival in Patients With Liver Cirrhosis
2005
Treatment of Alcoholic Liver Disease
2005
Gastrointestinal symptoms in patients with liver cirrhosis: Associations with nutritional status and health-related quality of life
2006
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Nutritional Support
1997
Characterization of fecal microbial communities in patients with liver cirrhosis
2011
Long-term Prognosis of Cirrhosis After Spontaneous Bacterial Peritonitis Treated With Ceftriaxone
2001
Acute Cytomegalovirus Infection Is a Risk Factor in Refractory and Complicated Inflammatory Bowel Disease
2008
Advances in alcoholic liver disease
2003
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
2015
Down's syndrome
2003 Standout
The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
2015
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
2014
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Branched-Chain Amino Acid Enriched Supplements as Therapy for Liver Disease
2006
Gastrointestinal dysfunction in liver cirrhosis
2014
Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial
1997
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
Factors affecting outcomes in Crohn's disease over 15 years
2012
High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics
2005
Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis
2002
Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense
2011
Nutritional support in patients with chronic liver disease
2006
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Catabolic response to stress and potential benefits of nutrition support
2002
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
2011
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
2008
Smoking in inflammatory bowel disease: Impact on disease course and insights into the aetiology of its effect
2014
Nutritional supplementation in Down syndrome: theoretical considerations and current status
2000
Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites
2000
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data
2010
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor
2009
Gut Transit Is Associated With Gastrointestinal Symptoms and Gut Hormone Profile in Patients With Cirrhosis
2008
Bacterial Translocation Up–Regulates Gtp–Cyclohydrolase I in Mesenteric Vasculature of Cirrhotic Rats
2003
Environmental enteropathy: critical implications of a poorly understood condition
2012
Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease
2009
The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms
2015
Alcoholic Liver Disease
2009
Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis
2005
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Nutrition Support in Clinical Practice: Review of Published Data and Recommendations for Future Research Directions
1997
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Guidelines for the management of inflammatory bowel disease in adults
2004
Baterial Translocation in Humans
2001
Nutrition Support and Infections Associated With Hepatic Resection and Liver Transplantation in Patients With Chronic Liver Disease
2012
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Dysbiosis of fecal microbiota in Crohnʼs disease patients as revealed by a custom phylogenetic microarray
2010
Bacterial translocation (BT) in cirrhosis†
2005
Alcoholic steatohepatitis
2010
Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis
2002
Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis
2001
Prevention of Gram-Negative Translocation Reduces the Severity of Hepatopulmonary Syndrome
2002
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
A review of the epidemiological evidence for the ‘antioxidant hypothesis’
2004
Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study
2014
Methotrexate for induction of remission in refractory Crohn's disease
2014
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Gut flora and bacterial translocation in chronic liver disease
2006
Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease
2001
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
Microbial Translocation in Chronic Liver Diseases
2012
Methotrexate for maintenance of remission in Crohn's disease
2014
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study
1995
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Alcoholic Hepatitis
2009
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
2016
Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation
2004
Enteral nutritional therapy for induction of remission in Crohn's disease
2007
Role of Nutrition in the Management of Hepatic Encephalopathy in End-Stage Liver Failure
2010
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
2012
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
1997
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis
2008
Antibiotic prophylaxis in cirrhosis: Good and bad
2015
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Gut Microbiota and Host Reaction in Liver Diseases
2015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
2015
Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease
2013
Intestinal absorption of water-soluble vitamins in health and disease
2011
Works of Eduard Cabré being referenced
Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.
1993
Enteral nutrition as primary therapy in Crohn's disease.
1994
Advanced Liver Fibrosis in HIV/HCV-Coinfected Patients on Antiretroviral Therapy
2004
Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis
2016
Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status
2002
Clinical outcome of newly diagnosed Crohn’s disease: a comparative, retrospective study before and after infliximab availability
2009
Sexual function and patients' perceptions in inflammatory bowel disease: a case–control survey
2012
ESPEN Guidelines on Enteral Nutrition: Liver disease
2006
Omega-3 fatty acids and inflammatory bowel diseases – a systematic review
2012
Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?
2005
Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease
2010
Changes in mucosal fatty acid profile in inflammatory bowel disease and in experimental colitis: a common response to bowel inflammation
1997
Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics
1990
Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel Disease
2006
Translocated intenstinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence
1998
Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids
2011
Does active smoking really influence the course of Crohn's disease? A retrospective observational study
2012
Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice
2009
Effect of the administration of fermentable and non-fermentable dietary fibre on intestinal bacterial translocation in ascitic cirrhotic rats
2007
Azathioprine without oral ciclosporin in the long‐term maintenance of remission induced by intravenous ciclosporin in severe, steroid‐refractory ulcerative colitis
2002
Impact of azathioprine on the prevention of postoperative Crohnʼs disease recurrence: Results of a prospective, observational, long-term follow-up study
2008
ESPEN Guidelines on Parenteral Nutrition: Hepatology
2009
Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study
2005
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety
2003
Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock
1996
Impact of environmental and dietary factors on the course of inflammatory bowel disease
2012
Nutrition in liver disease
2005
Cytomegalovirus Infection in Patients With Inflammatory Bowel Disease
1999
Long-term Methotrexate for Crohn's Disease
2008
Impact of Capsule Endoscopy Findings in the Management of Crohn’s Disease
2009
Nutrition in inflammatory bowel disease
2001
Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis
2000
Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey
2013
Hypertransaminasemia in Pediatric Celiac Disease Patients and Its Prevalence as a Diagnostic Clue
2002
Infliximab Reintroduction is Not Associated to a Higher Rate of Immune-related Adverse Effects in Patients With Inflammatory Bowel Disease Initially Treated With a Three-infusion Induction Regimen
2009
Addition of Metronidazole to Azathioprine for the Prevention of Postoperative Recurrence of Crohn’s Disease
2013
Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy
2008
Nutrition in chronic liver disease and liver transplantation
1998
How Effective Is Enteral Nutrition in Inducing Clinical Remission in Active Crohn's Disease? A Meta‐Analysis of the Randomized Clinical Trials
1995
Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: Long-term hemodynamic and renal effects
1994
Regenerating gene Iα is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study
2011
Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination
1997
Predictors of Clinical Response to Systemic Steroids in Active Ulcerative Colitis
2006
Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis
2000
Prospective, Observational, Cross-Sectional Study of Intestinal Infections among Acutely Active Inflammatory Bowel Disease Patients
2009
Long-term Comparative Efficacy of Cyclosporine- or Infliximab-based Strategies for the Management of Steroid-refractory Ulcerative Colitis Attacks
2014
Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis.
1994
Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study.
1993
ESPEN Guidelines on Parenteral Nutrition: Gastroenterology
2009
Clinical and nutritional factors predictive of plasma lipid unsaturation deficiency in advanced liver cirrhosis: a logistic regression analysis.
1993
Effect of cisapride upon jejunal bacterial flora and bacterial translocation in ascitic cirrhotic rats
1998
Fat composition is the differential factor to explain the primary therapeutic effect of enteral nutrition in Crohn's disease. Results of a double-blind, randomized, multicenter european trial
2000
The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis.
1993
Antioxidant enzymes and fatty acid status in erythrocytes of Down syndrome patients
1998
Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice.
2011
Vitamin status in patients with inflammatory bowel disease.
1989
Nutritional aspects of chronic liver disease
1993
Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients.
1998
Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial
2000
Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics.
1993
Nutritional support in liver disease.
1995
Nutrition in inflammatory bowel disease: impact on disease and therapy
2001
A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding
1994